[DrBazza]

> Approval doesn't matter when AZ has to build stock to meet deadlines. Basically they weren't building stock to fulfill UK orders, from EU based production.

Vaccine delivery, like pretty much everything else, is just-in-time delivery. They haven't been building stocks. They've been manufacturing vaccines and shipping them straight out as they have signed contracts with many other countries other than the UK. Demand is outstripping supply.

The EU's argument, which is well documented in the press, is that they've promised about 300 million Euros to AZ to build up capacity, only a small amount of which they've paid AZ. It is also well documented that it takes time to get a vaccine manufacturing plant working at close to 100% yield, something even the UK plant hasn't achieved. It's simply the case that the EU should have agreed and paid sooner so that AZ could have invested that money in the EU plants sooner. All of this is covered in the 'best reasonable efforts' parts of the contract.

> It takes months to build stock, but they were flushing that stock to UK.

Evidence? As far as I can see in the press, the AZ doses in the UK are coming from the AZ manufacturing plants in the UK, and it is vdL / the EU that is demanding that AZ doses in the UK are diverted to the EU to make up the current shortfall in EU manufacturing.

[libertine]

>Vaccine delivery, like pretty much everything else, is just-in-time delivery. They haven't been building stocks. They've been manufacturing vaccines and shipping them straight out as they have signed contracts with many other countries other than the UK. Demand is outstripping supply.

Vaccine production started before any country gave any approval, it's well documented that it started in 5th JUNE 2020, so I don't quite get what you're saying. If it took Europe 4 more weeks to approve a vaccine all the stock produced until that point should have been flushed to countries who approved it before, even though the production started way before anyone approved - so they take advantage of stock build up, but Europe doesn't because?

>The EU's argument, which is well documented in the press, is that they've promised about 300 million Euros to AZ to build up capacity, only a small amount of which they've paid AZ. It is also well documented that it takes time to get a vaccine manufacturing plant working at close to 100% yield, something even the UK plant hasn't achieved. It's simply the case that the EU should have agreed and paid sooner so that AZ could have invested that money in the EU plants sooner. All of this is covered in the 'best reasonable efforts' parts of the contract.

Again, something doesn't add up - it's well documented that it was EUROPEAN factories in the Netherlands and Germany that produced the first batches of AZ vaccines for the UK. So even before UK has any production capacity they are already taking advantage of Europe capacity of production financed by EU.

Basically the UK took advantage of EU capacity, and EU didn't get anything out of their investment? And now that UK has some capacity, all of it will be for UK, and EU should keep investing to make vaccines for UK and the rest of the world, while AZ is failing to fulfill orders.

This is weird, no?

>Evidence? As far as I can see in the press, the AZ doses in the UK are coming from the AZ manufacturing plants in the UK, and it is vdL / the EU that is demanding that AZ doses in the UK are diverted to the EU to make up the current shortfall in EU manufacturing.

It's well documented in the media, quote:

"Ian McCubbin, the manufacturing lead for the UK's Vaccine Taskforce said that the “vast majority” of the Oxford/AstraZeneca vaccine will be manufactured in the UK.

AstraZeneca also has some plants in Europe, with sites in Germany and the Netherlands producing the jab - these were the first to be rolled out in the UK."

Source: https://www.business-live.co.uk/manufacturing/uk-factories-m...

[DrBazza]

I'm saying demand is outstripping supply and there aren't (huge) stockpiles of vaccines. The UK AZ plant is yet running at 100% yield according to the AZ chairman, and the EU plants are further behind. If there were 100% supply, the UK would be even further ahead in its doses-administered.

> Basically the UK took advantage of EU capacity

It's not the UK that took advantage, if the vaccines originated in an EU plant, it's that AZ chose to supply doses to the UK from the EU plant to meet its contractual 'best efforts' obligation, not the UK.

That's my point from earlier that the media are trying to draw the UK into this as some kind of post-Brexit spat with the EU, and that the UK gov. have rightly been quiet on the whole thing so far. That's also, partly, the EU's view on it as well, which is one of the reasons I suppose why they 'raided' the plants in the EU.